SBC Medical Group Holdings Incorporated (SBC) Stock Overview
Explore SBC Medical Group Holdings Incorporated’s financial performance, market position, analyst ratings, and future outlook.
SBC Medical Group Holdings Incorporated (SBC)
Key Financials
Key Financials
Market Cap
314.7M
P/E Ratio
7.72
EPS (TTM)
$0.39
ROE
0.16%
SBC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of SBC Medical Group Holdings Incorporated (NASDAQ: SBC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SBC Medical Group Holdings Incorporated's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SBC on the NASDAQ shows an RSI of 49.90, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.53 for the NASDAQ listing.
Key metrics behind SBC Medical Group Holdings Incorporated's NASDAQ-traded stock include a P/E ratio of 7.72 and a market capitalization of 314.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SBC on the NASDAQ.